• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低携带 BRCA1/2 突变可能性女性对遗传性乳腺癌风险的误解及其与信息分享动机的关系。

Misinterpretation of Hereditary Breast Cancer Risk and Its Association with Information Sharing Motives among Women at Low Likelihood of Carrying a BRCA1/2 Mutation.

机构信息

Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA,

Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

出版信息

Public Health Genomics. 2020;23(5-6):252-256. doi: 10.1159/000511131. Epub 2020 Oct 27.

DOI:10.1159/000511131
PMID:33108784
Abstract

PURPOSE

In this brief report, we ask whether women's interpretation of breast cancer risk based on their low likelihood of carrying a BRCA1/2 mutation is associated with their information-sharing behavior, and whether misinterpretation is associated with motives for sharing the result.

METHODS

Women in mammography clinics who completed a brief family history assessment and deemed to be at low likelihood of carrying a BRCA1/2 mutation were asked to complete a 1-time online survey between June 2016 and January 2017.

RESULTS

One-third (44/148) of women shared their family history screen result with someone in their social network. Result information was shared largely with a first-degree female relative to express feelings of relief (77%, 33/43). There were no differences in likelihood of sharing based on breast cancer risk interpretation. However, women who misinterpreted the implications of the result for general breast cancer risk reported more motives to share the result with their social network than those who accurately interpreted their breast cancer risk.

CONCLUSIONS

As family history-based screening for hereditary breast cancer is broadly implemented, the communication needs of the majority of women who will be unlikely of carrying a BRCA1/2 mutation must be considered. The motives of women who misinterpreted the implications of this result for breast cancer risk suggest the possibility that miscommunication could be spread to the broader family network.

摘要

目的

在这份简短的报告中,我们探讨了女性基于自身携带 BRCA1/2 突变低可能性对乳腺癌风险的解读,是否与其信息共享行为相关,以及是否存在误解,以及这种误解是否与分享结果的动机相关。

方法

在 2016 年 6 月至 2017 年 1 月期间,我们在乳腺摄影诊所中招募了完成简短家族史评估且被认为携带 BRCA1/2 突变低可能性的女性,要求她们完成一次在线调查。

结果

三分之一(44/148)的女性与社交网络中的某人分享了她们的家族史筛查结果。结果信息主要与一级女性亲属分享,以表达解脱感(77%,33/43)。但是,基于对结果的乳腺癌风险解读,分享的可能性没有差异。然而,与准确解读其乳腺癌风险的女性相比,误解结果对一般乳腺癌风险影响的女性报告了更多分享结果给社交网络的动机。

结论

随着基于家族史的遗传性乳腺癌筛查的广泛实施,必须考虑到大多数不太可能携带 BRCA1/2 突变的女性的沟通需求。误解这一结果对乳腺癌风险影响的女性的动机表明,错误信息可能会传播到更广泛的家庭网络。

相似文献

1
Misinterpretation of Hereditary Breast Cancer Risk and Its Association with Information Sharing Motives among Women at Low Likelihood of Carrying a BRCA1/2 Mutation.低携带 BRCA1/2 突变可能性女性对遗传性乳腺癌风险的误解及其与信息分享动机的关系。
Public Health Genomics. 2020;23(5-6):252-256. doi: 10.1159/000511131. Epub 2020 Oct 27.
2
Do Women who Receive a Negative BRCA1/2 Risk Result Understand the Implications for Breast Cancer Risk?收到BRCA1/2风险检测结果为阴性的女性是否理解其对乳腺癌风险的影响?
Public Health Genomics. 2019;22(3-4):102-109. doi: 10.1159/000503129. Epub 2019 Oct 9.
3
Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.5 例在最初无疾病的 BRCA1 或 BRCA2 突变携带者中经筛查检出的乳腺癌病例。
Breast Cancer. 2019 Nov;26(6):846-851. doi: 10.1007/s12282-019-00971-6. Epub 2019 Apr 12.
4
Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.乳腺钼靶筛查与BRCA1和BRCA2突变携带者患乳腺癌的风险:一项前瞻性研究。
Breast Cancer Res Treat. 2014 Aug;147(1):113-8. doi: 10.1007/s10549-014-3063-y. Epub 2014 Aug 1.
5
Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores.包含对HER2扩增进行病理调整的风险算法需要在可能性评分上进一步向下调整。
Fam Cancer. 2017 Apr;16(2):173-179. doi: 10.1007/s10689-016-9942-0.
6
Building the What Comes Next Cohort for and testing: a descriptive analysis.构建用于[具体内容]和测试的“接下来会怎样”队列:描述性分析。 (注:原文中“Building the What Comes Next Cohort for and testing”里两个“for”后面的内容缺失)
CMAJ Open. 2021 Sep 21;9(3):E874-E885. doi: 10.9778/cmajo.20200228. Print 2021 Jul-Sep.
7
Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.60岁以上BRCA1和BRCA2突变携带者乳腺癌筛查的相关性和有效性:一项全国队列研究。
Int J Cancer. 2014 Dec 15;135(12):2940-9. doi: 10.1002/ijc.28941. Epub 2014 May 20.
8
Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.BRCA1和BRCA2突变携带者的乳腺钼靶筛查与乳腺癌风险:一项病例对照研究。
Lancet Oncol. 2006 May;7(5):402-6. doi: 10.1016/S1470-2045(06)70624-6.
9
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.基于人群的研究:BRCA1 或 BRCA2 基因突变携带者发生对侧原发性乳腺癌的风险。
J Clin Oncol. 2010 May 10;28(14):2404-10. doi: 10.1200/JCO.2009.24.2495. Epub 2010 Apr 5.
10
Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.BRCA1 和 BRCA2 基因突变非携带者且有乳腺癌家族史的女性发生对侧乳腺癌的风险:来自妇女环境癌症和辐射流行病学研究的报告。
J Clin Oncol. 2013 Feb 1;31(4):433-9. doi: 10.1200/JCO.2012.43.2013. Epub 2012 Dec 26.

引用本文的文献

1
Information needs persist after genetic counseling and testing for BRCA1/2 and Lynch Syndrome.遗传咨询和 BRCA1/2 和 Lynch 综合征检测后仍存在信息需求。
Breast Cancer Res Treat. 2024 Nov;208(1):19-27. doi: 10.1007/s10549-024-07377-9. Epub 2024 Jul 24.
2
Regarding the Yin and Yang of Precision Cancer- Screening and Treatment: Are We Creating a Neglected Majority?关于精准癌症筛查与治疗的阴阳:我们是否在忽视大多数?
Int J Environ Res Public Health. 2019 Oct 29;16(21):4168. doi: 10.3390/ijerph16214168.